COVID-19 Vaccine Perceptions among Ebola-Affected Communities in North Kivu, Democratic Republic of the Congo, 2021
- PMID: 37243077
- PMCID: PMC10223943
- DOI: 10.3390/vaccines11050973
COVID-19 Vaccine Perceptions among Ebola-Affected Communities in North Kivu, Democratic Republic of the Congo, 2021
Abstract
Populations affected by humanitarian crises and emerging infectious disease outbreaks may have unique concerns and experiences that influence their perceptions toward vaccines. In March 2021, we conducted a survey to examine the perceptions toward COVID-19 vaccines and identify the factors associated with vaccine intention among 631 community members (CMs) and 438 healthcare workers (HCWs) affected by the 2018-2020 Ebola Virus Disease outbreak in North Kivu, Democratic Republic of the Congo. A multivariable logistic regression was used to identify correlates of vaccine intention. Most HCWs (81.7%) and 53.6% of CMs felt at risk of contracting COVID-19; however, vaccine intention was low (27.6% CMs; 39.7% HCWs). In both groups, the perceived risk of contracting COVID-19, general vaccine confidence, and male sex were associated with the intention to get vaccinated, with security concerns preventing vaccine access being negatively associated. Among CMs, getting the Ebola vaccine was associated with the intention to get vaccinated (RR 1.43, 95% CI 1.05-1.94). Among HCWs, concerns about new vaccines' safety and side effects (OR 0.72, 95% CI 0.57-0.91), religion's influence on health decisions (OR 0.45, 95% CI 0.34-0.61), security concerns (OR 0.52, 95% CI 0.37-0.74), and governmental distrust (OR 0.50, 95% CI 0.35-0.70) were negatively associated with vaccine perceptions. Enhanced community engagement and communication that address this population's concerns could help improve vaccine perceptions and vaccination decisions. These findings could facilitate the success of vaccine campaigns in North Kivu and similar settings.
Keywords: Democratic Republic of the Congo; Ebola Virus Disease; SARS-CoV-2; humanitarian; outbreak; pandemic; vaccine acceptance; vaccine hesitancy; vaccines.
Conflict of interest statement
The authors have no conflicts of interest. The findings and conclusions in this paper are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention or International Medical Corps or any institutions that the authors are affiliated with.
References
-
- Christie A., Brooks J.T., Hicks L.A., Sauber-Schatz E.K., Yoder J.S., Honein M.A. Guidance for implementing COVID-19 prevention strategies in the context of varying community transmission levels and vaccination coverage. [(accessed on 21 September 2022)];Morb. Mortal. Wkly. Rep. 2021 70:1044. doi: 10.15585/mmwr.mm7030e2. Available online: https://pmc/articles/PMC8323553/ - DOI - PMC - PubMed
-
- COVID-19 Vaccination in the WHO African Region—10 November 2022|WHO|Regional Office for Africa. [(accessed on 27 November 2022)]. Available online: https://www.afro.who.int/publications/covid-19-vaccination-who-african-r....
-
- Nachega J.B., A Sam-Agudu N., Masekela R., van der Zalm M.M., Nsanzimana S., Condo J., Ntoumi F., Rabie H., Kruger M., Wiysonge C.S., et al. Addressing challenges to rolling out COVID-19 vaccines in African countries. [(accessed on 27 November 2022)];Lancet Glob. Health. 2021 9:e746–e748. doi: 10.1016/S2214-109X(21)00097-8. Available online: http://www.thelancet.com/article/S2214109X21000978/fulltext. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
